[1]闫向勇,燕忠生,李俊,等.中西医结合治疗新型冠状病毒肺炎临床观察[J].西部中医药,2020,33(S1):84.
　YAN Xiangyong,YAN Zhongsheng,et al.Clinical Observation of Integrative Medicine Therapy of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):84.
点击复制

中西医结合治疗新型冠状病毒肺炎临床观察()
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
33
期数:
2020年S1
页码:
84
栏目:
出版日期:
2025-06-30

文章信息/Info

Title:
Clinical Observation of Integrative Medicine Therapy of COVID-19
作者:
闫向勇1，2' target="_blank" rel="external">2' target="_blank" rel="external">2' target="_blank" rel="external">2，燕忠生1，李俊1，2' target="_blank" rel="external">2' target="_blank" rel="external">2' target="_blank" rel="external">2，王江雨1，2' target="_blank" rel="external">2' target="_blank" rel="external">2' target="_blank" rel="external">2，张炼1△
1 中国人民解放军联勤保障部队第九四〇医院,甘肃 兰州730050; 2 火神山医院中医治疗组
Author(s):
YAN Xiangyong1, 2' target="_blank" rel="external"> 2' target="_blank" rel="external"> 2' target="_blank" rel="external"> 2, YAN Zhongsheng1, LI Jun1, 2' target="_blank" rel="external"> 2' target="_blank" rel="external"> 2' target="_blank" rel="external"> 2, WANG Jiangyu1, 2' target="_blank" rel="external"> 2' target="_blank" rel="external"> 2' target="_blank" rel="external"> 2, ZHANG Lian1
1 Hospital 940 of PLA Joint Logistics Support Force, Lanzhou 730050, China; 2 TCM Therapy Group, Huoshenshan Hospital
关键词:
新型冠状病毒肺炎; 中医药; 中西医结合; 临床疗效
Keywords:
COVID-19;  TCM;  integrative medicine;  clinical effects
分类号:
R563
文献标志码:
A
摘要:
目的：观察中西医结合治疗新型冠状病毒肺炎(以下简称新冠肺炎)的临床疗效。方法：采用非随机对照的研究方法，将178例普通型新冠肺炎患者按意愿分为治疗组和对照组，对照组予西医常规治疗，治疗组在对照组治疗基础上联用温阳化湿方及湿热宣肺方治疗，比较两组患者临床症状消失率，淋巴细胞比率恢复情况及病情转归。结果：两组患者发热、咳嗽、乏力、胸闷气短、咽痛、肌肉酸痛等临床症状缓解率治疗组高于对照组，差异具有统计学意义(P＜0.05)；食欲下降改善两组患者比较差异无统计学意义(P＞0.05)。淋巴细胞恢复情况治疗组优于对照组，差异具有统计学意义(P=0.012)。进展为重型、危重型患者对照组多于治疗组，两组比较差异有统计学意义(P=0.034)。结论：中西医结合能明显改善新冠肺炎患者临床症状，促进淋巴细胞恢复，降低病情进展风险。
Abstract:
Objective: To assess clinical effects of integrative medicine therapy in the treatment of COVID-19 . Methods: Non randomized controlled study was adopted, all 178 patients with common type COVID-19 were allocated to the treatment group and the control group according to the wish, the control group accepted conventional theropy of Westera medicine, and the abservation group were TCM based on Western medicine, to compare the disappearing rate of clinical symptoms, the recovery of lymphocyte ratio and disease outcome between both groups. Results: The remission rate of clinical symptoms including fever, cough, weakness, chest tightness and shortness of breath, sore throat, muscle soreness and others of the treatment group was higher than that of the control group, and the difference had statistical meaning (P＜0.05); the difference had no statistical meaning in the improvements of anorexia between both groups(P＞0.05). The treatment group was superior to the control group in the recovery of lymphocyte ratio, and the difference showed statistical meaning(P=0.012). The control group was more than the treatment group in the number of developing into severe type and critical type, and the difference showed statistical meaning (P=0.034). Conclusion: Integrative medicine could notably improve clinical symptoms of the patients, promote the recovery of lymphocyte and lower the risk of disease progression.

参考文献/References:

[1] 杨海侠，张银萍，杨长虹，等.新型冠状病毒肺炎疑似患者留观隔离期的护理体会[J].西部中医药，2020，33(3):9-11.
[2] 宋忠阳，雍文兴，张利英，等.新型冠状病毒肺炎的中医临床特征与辨证论治——甘肃经验[J].西部中医药，2020，33(3):1-5.
[3] 国家卫生健康委员会办公厅，国家中医药管理局办公室.新型冠状病毒肺炎诊疗方案(试行第六版)[J].中国病毒病杂志，2020，10(2)：81-85.
[4] 北京协和医院新型冠状病毒感染的肺炎诊治专家组.北京协和医院关于“新型冠状病毒感染的肺炎”诊疗建议方案(V2.0)[J].中华内科杂志，2020，59(3):186-188.
[5] CHEN N S，ZHOU M，DONG X，et al.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan,China:a descriptive study[J].Lancet，2020，395(10223)：507-513.
[6] 李力，李琦，程金波，等.新型冠状病毒肺炎患者分层治疗与中医辅助治疗方案[J].第三军医大学学报，2020，42(4):427-430.
[7] 王宪波，刘景院，王晓静，等.新型冠状病毒肺炎诊治实践与体会[J].北京中医药，2020，39(2)：109-111.

相似文献/References:

[1]蔺彩娟,甘欣锦△.自拟三子补血汤 治疗化疗后骨髓抑制的经验[J].西部中医药,2012,25(10):47.
　LIN Cai-juan,GAN Xin-jin.Experience on Treating Arrest of Bone Marrow after Chemotherapy with Self-made SanZi BuXueTang[J].Western Journal of Traditional Chinese Medicine,2012,25(S1):47.
[2]王 磊,魏 彪.中医药在自体脂肪移植隆胸术中的应用价值[J].西部中医药,2012,25(10):83.
　WANG Lei,WEI Biao.Value of Chinese Medicine to Autogenous Fat Graft Breast Augmentation Surgery[J].Western Journal of Traditional Chinese Medicine,2012,25(S1):83.
[3]聂静怡,应森林.周边国家和地区中医药国际教育需求分析[J].西部中医药,2013,26(01):48.
　NIE Jingyi,YING Senlin.Analysis on the Demand of TCM International Education in the Districts and Its Neighboring Countries[J].Western Journal of Traditional Chinese Medicine,2013,26(S1):48.
[4]舒劲,杨宏武.中医药在突发公共卫生事件中的应用与探讨[J].西部中医药,2013,26(01):59.
　SHU Jin,YANG Hongwu.Exploration and Application of TCM in the Public Health Emergencies[J].Western Journal of Traditional Chinese Medicine,2013,26(S1):59.
[5]鲁培俊,文建强,王冠华,等.兰州市社区卫生服务机构中医药健康教育资源现状调查分析[J].西部中医药,2013,26(01):72.
　LU Peijun,WEN Jianqiang,WANG Guanhua,et al.Investigation on Current State of TCM Health Education Resources in Lanzhou Community Health Service Institutes[J].Western Journal of Traditional Chinese Medicine,2013,26(S1):72.
[6]张海清,赵继荣△,陈文.腰椎间盘突出症的中医药治疗概述[J].西部中医药,2012,25(12):124.
　ZHANG Hai-qing,ZHAO Ji-rong,CHEN Wen.On TCM Therapy for Lumbar Intervertebral Disc Protrusion[J].Western Journal of Traditional Chinese Medicine,2012,25(S1):124.
[7]李方圆,韩树堂△.重症急性胰腺炎中西医结合治疗的思考[J].西部中医药,2013,26(02):126.
　LI Fangyuan,HAN Shutang.Thinking on Treating Severe Acute Pancreatitis with Integrative Medicine[J].Western Journal of Traditional Chinese Medicine,2013,26(S1):126.
[8]马忠祥,李 玲△.欠发达地区推广中医药防治职业病可行性浅析[J].西部中医药,2012,25(11):55.
　MA Zhong-xiang,LI Ling.Popularization Feasibility of TCM Preventing Occupational Diseases in the Underdevelopment Area[J].Western Journal of Traditional Chinese Medicine,2012,25(S1):55.
[9]钱国宏,文建强,王玉,等.新医改形势下甘肃省中医药防病与健康教育活动探讨[J].西部中医药,2013,26(05):54.
　QIAN Guohong,WEN Jianqiang,et al.On TCM Prevention and Health Education Launched in Gansu Province under the Background of New Medical Reform[J].Western Journal of Traditional Chinese Medicine,2013,26(S1):54.
[10]刘明龙,曾永祥,赵健雄,等.中医药抗肾间质纤维化的研究[J].西部中医药,2013,26(05):123.
　LIU Minglong,ZENG Yongxiang,ZHAO Jianxiong,et al.Research on TCM Against Renal Interstitial Fibrosis[J].Western Journal of Traditional Chinese Medicine,2013,26(S1):123.
[11]桑天庆,周红光△.中医药在新型冠状病毒肺炎疫情中的应用[J].西部中医药,2020,33(S1):18.
　SANG Tianqing,ZHOU Hongguang.TCM Applied to Epidemic Situation of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):18.
[12]曾建峰,李乐愚,缪灿铭,等.岭南道地药材在中山地区新型冠状病毒肺炎防治中的应用*[J].西部中医药,2020,33(S1):24.[doi:10.1056/NEJMoa-2001017]
　and Treatment of COVID-9 in Zhongshan Region.The Application of Lingnan Genuine Drugs to the Prevention[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):24.[doi:10.1056/NEJMoa-2001017]
[13]李跃彤,黄平平△.全国名中医防治新型冠状病毒肺炎方案汇总分析[J].西部中医药,2020,33(S1):34.
　LI Yuetong,HUANG Pingping.An Analysis of National Famous TCM Doctors’ Prevention and Treatment Regimens of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):34.
[14]邓鑫,朱文琳,王建超,等.基于“三因制宜”理论探讨新型冠状病毒肺炎的中医药防治[J].西部中医药,2020,33(S1):40.
　DENG Xin,ZHU Wenlin,WANG Jianchao,et al.TCM Prevention and Treatment of COVID - 19 Based on the Theory of Treatment Individualized to Patients, Season and Locality"[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):40.
[15]王兰娣,杨志华,王建云,等.“甘肃方剂”救治新型冠状病毒肺炎患者临床效果分析[J].西部中医药,2020,33(S1):54.
　WANG Landi,YANG Zhihua,WANG Jianyun,et al.Clinical Analysis of Gansu Prescriptions in Treating COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):54.
[16]李跃彤,黄平平.全国各中医临床专家防治新型冠状病毒肺炎方案汇总分析[J].西部中医药,2020,33(07):1.[doi:10.12174/j.issn.1004-6852.2020.07.01]
　LI Yuetong,HUANG Pingping.An Analysis of National Famous TCM Doctors' Prevention and Treatment Regimens of COVID-19[J].Western Journal of Traditional Chinese Medicine,2020,33(S1):1.[doi:10.12174/j.issn.1004-6852.2020.07.01]
[17]于海洋,秦忠,李文,等.金水宝胶囊治疗新型冠状病毒肺炎后遗症的临床应用价值[J].西部中医药,2022,35(04):1.[doi:10.12174/j.issn.2096-9600.2022.04.01]
　YU Haiyang,QIN Zhong,LI Wen,et al.Clinical Application Value of Jinshuibao Capsules in the Treatment of Sequelae of COVID-19[J].Western Journal of Traditional Chinese Medicine,2022,35(S1):1.[doi:10.12174/j.issn.2096-9600.2022.04.01]
[18]李思思,杨金月,赵勇,等.基于CiteSpace的中医药治疗新型冠状病毒肺炎知识图谱分析[J].西部中医药,2022,35(05):9.[doi:10.12174/j.issn.2096-9600.2022.05.02]
　LI Sisi,YANG Jinyue,ZHAO Yong,et al.Analysis of Knowledge Map of TCM Therapy of COVID-19 Based on CiteSpace[J].Western Journal of Traditional Chinese Medicine,2022,35(S1):9.[doi:10.12174/j.issn.2096-9600.2022.05.02]
[19]徐艺倪,王建超,王淼东,等.基于抗肺纤维化的用药规律分析新型冠状病毒肺炎的中医治疗[J].西部中医药,2022,35(06):12.[doi:10.12174/j.issn.2096-9600.2022.06.04]
　XU Yini,WANG Jianchao,WANG Miaodong,et al.An Analysis of TCM Therapy for COVID-19 Based on the Medication Laws of Anti-lung Fibrosis[J].Western Journal of Traditional Chinese Medicine,2022,35(S1):12.[doi:10.12174/j.issn.2096-9600.2022.06.04]
[20]曾建峰,李乐愚,缪灿铭,等.岭南道地药材在中山地区新型冠状病毒肺炎防治中的应用[J].西部中医药,2021,34(12):1.[doi:10.12174/j.issn.2096-9600.2021.12.01]
　ZENG Jianfeng,LI Leyu,MIU Canming,et al.The Application of Lingnan Genuine Drugs in the Prevention and Treatment of COVID-19 in Zhongshan Region[J].Western Journal of Traditional Chinese Medicine,2021,34(S1):1.[doi:10.12174/j.issn.2096-9600.2021.12.01]

备注/Memo

备注/Memo:
*基金项目：院内“新冠肺炎(COVID-19)”应急医学科研项目(20yjky-009)。 收稿日期：2020-03-06 *基金项目：院内“新冠肺炎(COVID-19)”应急医学科研项目(20yjky-009)。 作者简介：闫向勇(1980—)，男，硕士学位，主治医师。研究方向：内科疾病的中西医结合诊治。 △通讯作者：张炼(1981—)，男，硕士学位，主治医师。
更新日期/Last Update: 2020-08-14